-
-
-
-
-
-
-
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report onĀ Form 10-K
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Eagle Pharmaceuticals (EGRX) Tops Q2 EPS by 11c ; offers Guidance
-
-
-
-
-
-
-
Eagle Pharmaceuticals (EGRX) Tops Q1 EPS by 33c; Offers FY23 EPS Guidance
-
-
-
-
-
-
-
Eagle Pharmaceuticals Provides Business Update and Guidance for 2023
-
-
-
-
-
-
-
Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group plc, Expanding Acute Care Footprint
-
-
-
-
-
-
-
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022
-
1,197,344 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

